<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0413066</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2830</journal-id>
<journal-id journal-id-type="nlm-ta">Cell</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell</journal-id>
<journal-title-group>
<journal-title>Cell</journal-title>
</journal-title-group>
<issn pub-type="ppub">0092-8674</issn>
<issn pub-type="epub">1097-4172</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28340352</article-id>
<article-id pub-id-type="pmc">5456452</article-id>
<article-id pub-id-type="doi">10.1016/j.cell.2017.03.007</article-id>
<article-id pub-id-type="manuscript">NIHMS858639</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Human epistatic interaction controls IL7R splicing and increases Multiple Sclerosis risk</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Galarza-Muñoz</surname>
<given-names>Gaddiel</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Briggs</surname>
<given-names>Farren B.S.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Evsyukova</surname>
<given-names>Irina</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schott-Lerner</surname>
<given-names>Geraldine</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kennedy</surname>
<given-names>Edward M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nyanhete</surname>
<given-names>Tinashe</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Liuyang</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bergamaschi</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Widen</surname>
<given-names>Steven G.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tomaras</surname>
<given-names>Georgia D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ko</surname>
<given-names>Dennis C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bradrick</surname>
<given-names>Shelton S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barcellos</surname>
<given-names>Lisa F.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gregory</surname>
<given-names>Simon G.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A10">10</xref>
<xref ref-type="author-notes" rid="FN3">†</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garcia-Blanco</surname>
<given-names>Mariano A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN3">†</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Molecular Genetics and Microbiology; Duke University Medical Center; Durham, NC, 27710; USA</aff>
<aff id="A2"><label>2</label>Center for RNA Biology; Duke University; Durham, NC, 27710; USA</aff>
<aff id="A3"><label>3</label>Department of Biochemistry and Molecular Biology; University of Texas Medical Branch; Galveston, TX, 77555; USA</aff>
<aff id="A4"><label>4</label>Department of Epidemiology and Biostatistics, School of Medicine; Case Western Reserve University; Cleveland, OH, 44106; USA</aff>
<aff id="A5"><label>5</label>Department of Immunology; Duke University; Durham, NC, 27710; USA</aff>
<aff id="A6"><label>6</label>Department of Surgery; Duke University; Durham, NC, 27710; USA</aff>
<aff id="A7"><label>7</label>Duke Molecular Physiology Institute; Duke University; Durham, NC, 27701; USA</aff>
<aff id="A8"><label>8</label>Department of Medicine; Duke University Medical Center; Durham, NC, 27710; USA</aff>
<aff id="A9"><label>9</label>Division of Epidemiology, School of Public Health, University of California, Berkeley, CA, 94720; USA</aff>
<aff id="A10"><label>10</label>Department of Neurology; Duke University Medical Center; Durham, NC, 27710; USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label><bold>Contact:</bold> Correspondence should be sent to Mariano A. Garcia-Blanco (<email>maragarc@utmb.edu</email>) or Simon G. Gregory (<email>simon.gregory@duke.edu</email>)</corresp>
<fn id="FN2">
<p>
<bold>Lead Contact:</bold>
</p>
<p>Mariano A. Garcia-Blanco (<email>maragarc@utmb.edu</email>)</p>
</fn>
<fn fn-type="equal" id="FN3">
<label>†</label>
<p>Authors contributed equally.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>22</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>23</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>3</month>
<year>2018</year>
</pub-date>
<volume>169</volume>
<issue>1</issue>
<fpage>72</fpage>
<lpage>84.e13</lpage>
<!--elocation-id from pubmed: 10.1016/j.cell.2017.03.007-->
<abstract id="Abs1">
<p id="P1">Multiple Sclerosis (MS) is an autoimmune disorder where T cells attack neurons in the central nervous system (CNS) leading to demyelination and neurological deficits. A driver of increased MS risk is the soluble form of the interleukin-7 receptor alpha chain gene (sIL7R), produced by alternative splicing of IL7R exon 6. Here, we identified the RNA helicase DDX39B as a potent activator of this exon and consequently a repressor of sIL7R, and found strong genetic association of <italic>DDX39B</italic> with MS risk. Indeed, we showed that a genetic variant in the 5′ UTR of DDX39B reduces translation of DDX39B mRNAs and increases MS risk. Importantly, this <italic>DDX39B</italic> variant showed strong genetic and functional epistasis with allelic variants in <italic>IL7R</italic> exon 6. This study establishes the occurrence of biological epistasis in humans and provides mechanistic insight into the regulation of IL7R exon 6 splicing and its impact on MS risk.</p>
</abstract>
<abstract abstract-type="graphical" id="Abs2">
<title>eTOC Blurb</title>
<p id="P2">Increased risk for Multiple Sclerosis (MS), an autoimmune disease that damages the central nervous system, is associated with altered alternative splicing of Interleukin 7 receptor (IL7R) mRNAs that leads to elevated soluble IL7R. Here, we identify the RNA helicase DDX39B as a potent regulator of IL7R splicing, a repressor of soluble IL7R formation and a modifier of MS risk. We show that an MS-associated DDX39B 5′ UTR variant reduces DDX39B protein levels and shows strong genetic and functional epistasis with variants in IL7R.</p>
<p id="P3">
<graphic orientation="portrait" position="anchor" xlink:href="nihms858639u1.jpg"></graphic></p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>